Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00343824
Other study ID # 2006/224
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2006
Est. completion date July 31, 2010

Study information

Verified date December 2022
Source University Hospital, Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is to compare the treatment with two different silver-containing wound dressings: aquacel AG hydrofiber versus acticoat burn dressing.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date July 31, 2010
Est. primary completion date July 31, 2010
Accepts healthy volunteers No
Gender All
Age group N/A to 80 Years
Eligibility Inclusion Criteria: - Burn wounds with flux values, measured by Laser Doppler Imaging, corresponding with expected healing time between 7 and 21 days, flux values between 200 and 1000 (red-pink or pink-yellow-green colour) - Wounds treated with a hydrocolloid paste prior to LDI - Possibility to follow the complete treatment schedule until wound healing and participation on complete follow-up schedule - Informed consent - Partial thickness burns with TBSE < 40% Exclusion Criteria: - Mean flux values < 200 or > 1000 - TBSA > 40% - Impossibility to debride necrotic skin prior to LDI measurement - Wounds treated with any topical ointments or dressings other than hydrocolloid prior to LDI - Not following the complete treatment schedule or missing some evaluations during the follow-up period - Patient has any condition that seriously compromises the patient's ability to complete the study - Patient has participated in another study using an investigational drug within the previous 30 days - Patient has one or more medical condition(s)that in the opinion of the investigator would make the patient an inappropriate candidate for this study - The plastic surgeon decides that surgery is necessary due to unusual circumstances - Patient wish to decline from the study - No informed consent - Full thickness burns

Study Design


Intervention

Procedure:
aquacel AG hydrofiber versus acticoat burn dressing
Aquacel AG hydrofiber versus acticoat burn dressing will be compared.

Locations

Country Name City State
Belgium University Hospital Ghent Ghent

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of the efficacy of both wound dressings in controlling wound bioburden over a period of 21 days Over a period of 21 days
Secondary Comparison of blood silver levels Every week until woundhealing. In folluw-up: at 3, 6 and 12 months
Secondary Percentage of genetically-acquired resistance to silver Once after wound closure.
Secondary Healing time comparison Every 3 days until healing
Secondary Scar quality assessment At 1, 3, 6 and 12 months after wound closure
Secondary Cost-effectiveness Once after wound closure.
Secondary Health related quality of life At 1, 3, 6 and 12 months after wound closure